Business Wire

1. Mawi And CosmosID Collaborate To Enable More Precise Microbiome Analysis 1/13/2020

   Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces a collaboration with CosmosID to help advance understanding of microbiome complexity in different biological samples and environments

2. Veravas And Tymora Collaborate On Early Detection Alzheimer’s Testing 1/13/2020

   Veravas, Inc. and Tymora Analytical Operations, LLC announced today that they have entered into a strategic alliance to explore the integration of their respective technologies

3. Ovation Announces The Advent Of Automated System Validation To Ease Regulatory Burden Of Clinical Laboratory Teams 1/13/2020

   Ovation.io, Inc . (Ovation), a next-generation clinical informatics company and makers of the fastest growing clinical laboratory information and commercialization system, today announced a revolutionary new validation tool for clinical laboratories called Automated Systems Validation (ASV)

4. QIAGEN Celebrates Surpassing 2,500 Cumulative Placements Of QIAsymphony 1/9/2020

   QIAGEN N.V. today announced the 2,500th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide, in Tübingen, Germany

5. PPD Expanding Clinical Development And Laboratory Capabilities In China 1/9/2020

   PPD, Inc. (PPD) has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies

6. Botanacor Opens New State-Of-The-Art Lab Facility, Increasing Hemp & CBD Testing Capacity Ten Fold, As Demand For Its Services Grows 1/6/2020

   Botanacor Laboratories, the widely recognized leader in accredited testing of hemp biomass and hemp-derived CBD products, today announced that is has opened a new state-of-the-art laboratory testing facility in Denver

7. Effepharm Announced Acquisitions And New R&D Center Establishment 12/12/2019

   Effepharm is thrilled to announce that they acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has significantly enhanced its R&D capability in anti-aging and energy metabolism

8. ELITechGroup Inc., World Leader For Laboratory Diagnosis Of Cystic Fibrosis Launches Macroduct Advanced – A Sweat Induction And Collection Method – In Canada 12/9/2019

   ELITechGroup Inc., known for worldwide transformation and innovation of sweat testing with the Webster Sweat Inducer and Macroduct Sweat Collection System, endorsed by the U.S. Cystic Fibrosis Foundation and other global CF associations, announces the release of the new Macroduct Advanced Sweat Collection System in Canada

9. Lantheus Enters Into Strategic Collaboration With CarThera For Use Of Microbubbles In Combination With SonoCloud System For Treatment Of Glioblastoma 12/9/2019

   Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced it has entered into a strategic commercial supply agreement with CarThera for the use of Lantheus’ microbubbles in combination with SonoCloud, a proprietary implantable device in development for the treatment of recurrent glioblastoma (rGBM)

10. Veracyte Acquires Exclusive License To NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally 12/3/2019

    Veracyte today announced that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use